Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US5008284A · kind A · utility
12Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 1989 |
| Grant date | Apr 16, 1991 |
| Priority date | — |
| Expiry date | Dec 18, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/49
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Zofenopril, fosinopril, (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-pro line or a pharmaceutically acceptable salt thereof alone or in combination with a thrombolytic, antiarrhythmic, or antifibrillatory agent is employed to reduce pre- and post-ischemic myocardial arrhythmias and fibrillations as well as reducing arrhythmias associated with congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.